まとめ
急性山病 (AMS) は,慣れていないハイカーの半数以上に影響し,より速く登り,より若い年齢でリスクが高まります. アセタゾラミドは,高度に飛行する人のためにAMSを予防するのに役立ちます.
科学分野:
- 高地医学は,高地医学である.
- 高空生理学 高空生理学
- 旅行 健康 旅行 健康
背景:
- 急性山病 (AMS) とその重症形態である高山肺腫 (HAPO) と脳腫 (CO) は,高山に慣れていない個人に重大なリスクをもたらします.
- AMSの発生率とリスク要因を理解することは,ヒマラヤのような山岳地帯で効果的な予防と治療戦略を開発するために不可欠です.
研究 の 目的:
- ネパール・ヒマラヤの4243mの高さでの急性山病 (AMS) とその合併症の発生率と重症度を調査する.
- AMSの発症と重症度に関連するリスク要因を特定する.
- AMSの予防と治療におけるアセタゾラミドの有効性を評価する.
主な方法:
- ヒマラヤのフェリチェ (4243 m) で,気候に適応していない278人のハイカーを対象に研究が行われました.
- 収集されたデータには,AMS,HAPO,COの発生率,年齢,登山プロファイル,適応,薬物使用などの要因が含まれています.
- アセタゾラミドの有効性は,プラセボと無薬との比較によるダブルブラインド試験で評価されました.
主要な成果:
- AMSの全体的な発生率は53%で,若い個体,2800mに飛び,急速に登り,適応夜数が少ない個体ではより高い割合でした.
- AMSの重症度は登山速度と相関し,年齢と逆相関する.
- アセタゾラミドは,2800mまで飛んだハイカーでAMSの発生率と重症度を大幅に低下させましたが,その高度までハイキングしたハイカーではそうではありませんでした.
結論:
- AMSの予防には,ゆっくりと登り,警告信号を迅速に認識し,適時に下りることが必要です.
- アセタゾラミドは,航空機を介して中程度の高度に急上昇する個人にAMSを予防するのに有効です.
- 重度の高山病の危険因子には,急速な登山,不十分な適応,若い年齢などがあります.
関連する概念動画
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...